Skip to Main Content

Paper Details

Therapeutic Implications for Intrinsic Phenotype Classification of Metastatic Castration-Resistant Prostate Cancer.
Clin Cancer Res
14
2022
AR, Basal, Basal subtype tumors, Basal tumors, IL6, LumA, LumA subtype, LumA subtype tumors, LumB subtype tumors, MYC, Metastatic Castration-Resistant Prostate Cancer, NOTCH, RNAseq, STAT3, TGF, adult, adult stem cell, androgen, androgen receptor, breast cancer, docetaxel, mCRPC, mCRPC tumors, mCRPCs, metastatic castration-resistant prostate cancers, neuroendocrine, neuroendocrine tumors, patient, patients, tumors
Author NameAffiliation
Ilsa ColemanFred Hutchinson Cancer Research Center, University of Washington
Ilsa ColemanDivision of Clinical Research, Fred Hutchinson Cancer Research Center, University of Washington
Colm MorrisseyUniversity of Washington
Eva CoreyUniversity of Washington
Michael C HaffnerFred Hutchinson Cancer Research Center, University of Washington
Michael C HaffnerDivision of Clinical Research, Fred Hutchinson Cancer Research Center, University of Washington
Michael C HaffnerUniversity of Washington
Peter S NelsonFred Hutchinson Cancer Research Center, University of Washington
Peter S NelsonDivision of Clinical Research, Fred Hutchinson Cancer Research Center, University of Washington
Peter S NelsonUniversity of Washington
Peter S NelsonUniversity of Washington
Peter S NelsonUniversity of Washington
Peter S NelsonFred Hutchinson Cancer Research Center, University of Washington
Peter S NelsonDivision of Clinical Research, Fred Hutchinson Cancer Research Center, University of Washington
Peter S NelsonUniversity of Washington
Peter S NelsonUniversity of Washington
Peter S NelsonUniversity of Washington
  • 1 - 17

Datasets

Release 1.2